» Articles » PMID: 11686869

Th2 Cytokines and Asthma. Interleukin-9 As a Therapeutic Target for Asthma

Overview
Journal Respir Res
Specialty Pulmonary Medicine
Date 2001 Nov 1
PMID 11686869
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Asthma is a complex heritable inflammatory disorder of the airways in which the development of clinical disease depends on environmental exposure. It has been well established that T helper type 2 (TH2) lymphocytes and their cytokines have an important role in allergic asthma. Interleukin (IL)-9, a member of the TH2 cytokine family, has recently been implicated as an essential factor in determining mucosal immunity and susceptibility to atopic asthma. In this review we examine the critical experiments and observations that support this hypothesis. We also discuss these results in comparison with the experiments supporting the involvement of other T H2 cytokines such as IL-4, IL-5 and IL-13.

Citing Articles

IL-9 aggravates SARS-CoV-2 infection and exacerbates associated airway inflammation.

Sadhu S, Dalal R, Dandotiya J, Binayke A, Singh V, Tripathy M Nat Commun. 2023; 14(1):4060.

PMID: 37429848 PMC: 10333319. DOI: 10.1038/s41467-023-39815-5.


In utero exposures to mint-flavored JUUL aerosol impair lung development and aggravate house dust mite-induced asthma in adult offspring mice.

Cahill K, Johnson T, Perveen Z, Schexnayder M, Xiao R, Heffernan L Toxicology. 2022; 477:153272.

PMID: 35878681 PMC: 9706914. DOI: 10.1016/j.tox.2022.153272.


Interleukin 9 serum level and single nucleotide polymorphism in patients with asthma.

Mahdaviani S, Eskian M, Khorasanizadeh M, Bashardoost B, Tashayoie Nejad S, Jamaati H Acta Biomed. 2021; 92(3):e2021206.

PMID: 34212923 PMC: 8343737. DOI: 10.23750/abm.v92i3.10544.


Glycogen synthase kinase-3 promotes T helper type 17 differentiation by promoting interleukin-9 production.

Han D, Medina-Rodriguez E, Lowell J, Beurel E Immunology. 2020; 160(4):357-365.

PMID: 32277469 PMC: 7370138. DOI: 10.1111/imm.13199.


Cytokines at the Interplay Between Asthma and Atherosclerosis?.

Gurgone D, McShane L, McSharry C, Guzik T, Maffia P Front Pharmacol. 2020; 11:166.

PMID: 32194407 PMC: 7064545. DOI: 10.3389/fphar.2020.00166.


References
1.
Grunig G, Warnock M, Wakil A, Venkayya R, Brombacher F, Rennick D . Requirement for IL-13 independently of IL-4 in experimental asthma. Science. 1998; 282(5397):2261-3. PMC: 3897229. DOI: 10.1126/science.282.5397.2261. View

2.
Renauld J, van der Lugt N, Vink A, van Roon M, Godfraind C, Warnier G . Thymic lymphomas in interleukin 9 transgenic mice. Oncogene. 1994; 9(5):1327-32. View

3.
Kon O, Kay A . T cells and chronic asthma. Int Arch Allergy Immunol. 1999; 118(2-4):133-5. DOI: 10.1159/000024049. View

4.
Vink A, Warnier G, Brombacher F, Renauld J . Interleukin 9-induced in vivo expansion of the B-1 lymphocyte population. J Exp Med. 1999; 189(9):1413-23. PMC: 2193070. DOI: 10.1084/jem.189.9.1413. View

5.
Levitt R, McLane M, MacDonald D, Ferrante V, Weiss C, Zhou T . IL-9 pathway in asthma: new therapeutic targets for allergic inflammatory disorders. J Allergy Clin Immunol. 1999; 103(5 Pt 2):S485-91. DOI: 10.1016/s0091-6749(99)70165-x. View